Baicalin Exerts Anti-Airway Inflammation and Anti-Remodelling Effects in Severe Stage Rat Model of Chronic Obstructive Pulmonary Disease

Figure 1

Effects of baicalin on pulmonary function of COPD rat model. (a) The FEV0.1/FVC ratio. (b) FRC. (c) Vital capacity (VC). (d) The TLC level. The data are shown as the mean ± the standard deviation (SD). p < 0.05 and p < 0.01 indicate a statistically significant difference compared to the model group; p < 0.05 and p < 0.01 indicate a statistically significant difference in model group compared with control group. FEV0.1, forced expiratory volume in 0.1 s; FRC, functional residual capacity; FVC, forced vital capacity; MMEF, maximum mild expiratory flow; TLC, total lung capacity.

(a)

(b)

(c)

(d)